FIRVANQ

Serial Number 87715534
Registration 5651067
702

Registration Progress

Application Filed
Dec 11, 2017
Under Examination
Jun 19, 2018
Approved for Publication
Apr 24, 2018
Published for Opposition
Apr 24, 2018
Registered
Jan 8, 2019

Trademark Image

FIRVANQ

Basic Information

Serial Number
87715534
Registration Number
5651067
Filing Date
December 11, 2017
Registration Date
January 8, 2019
Published for Opposition
April 24, 2018
Drawing Code
3

Status Summary

Current Status
Active
Status Code
702
Status Date
Mar 19, 2025
Registration
Registered
Classes
005

Rights Holder

AZURITY PHARMACEUTICALS, INC.

03
Address
8 CABOT ROAD, SUITE 2000
WOBURN, MA 01801

Ownership History

CutisPharma, Inc.

Original Applicant
03
Wilmington, MA

CutisPharma, Inc.

Owner at Publication
03
Wilmington, MA

CutisPharma, Inc.

Original Registrant
03
Woburn, MA

AZURITY PHARMACEUTICALS, INC.

New Owner After Registration #1
03
WOBURN, MA

Legal Representation

Attorney
Douglas R. Wolf

USPTO Deadlines

Next Deadline
1113 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20190108)
Due Date
January 08, 2029
Grace Period Ends
July 08, 2029

Application History

27 events
Date Code Type Description Documents
Mar 19, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Mar 19, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Mar 19, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Mar 19, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Nov 22, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jan 8, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Apr 29, 2020 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
May 23, 2019 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 23, 2019 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 26, 2019 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Mar 26, 2019 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 8, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 4, 2018 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Dec 3, 2018 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Nov 27, 2018 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Nov 6, 2018 IUAF S USE AMENDMENT FILED Loading...
Nov 27, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 6, 2018 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 19, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 24, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 24, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 4, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 22, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 22, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 21, 2017 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Dec 20, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 14, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
antibiotics; pharmaceutical preparations, namely, vancomycin for the treatment of colitis and gastrointestinal disorders in oral solution form, powder form and diluent form; pharmaceutical preparations, namely, vancomycin for the treatment of clostridium difficile and staphylococcus aureus colitis in oral solution form, powder form and diluent form
First Use Anywhere: Apr 2, 2018
First Use in Commerce: Apr 2, 2018

Additional Information

Design Mark
The mark consists of "FIRVANQ" in blue with curving tails of the "V" and "Q" in green.
Color Claim
The color(s) blue and green is/are claimed as a feature of the mark.

Classification

International Classes
005